Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.41%
+15.34%
-2.61%
-8.11%
-1.05%
NTRA
Natera
$187.90
Strengths
Upgraded on attractively valued
Chart
$163.79 (+14.72%)
$135.84 (+38.32%)
$157.73 (+19.13%)
$123.44 (+52.22%)
NTRA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
NTRA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
NTRA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NTRA Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
NTRA Earnings
The TTM reflects 12-month period, providing review of NTRA financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is NTRA current stock price?
What are NTRA stock strengths?
What risks are associated with NTRA stock?
When is NTRA next earnings report?
What is NTRA market cap and volume?
What is NTRA's current Stock IQ?
Should I buy NTRA stock right now?
Is NTRA a Strong Buy right now?
What does a 'Strong Buy' rating mean for NTRA?
What does a 'Strong Sell' rating mean for NTRA?
What factors influence NTRA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.41%
+15.34%
-2.61%
-8.11%
-1.05%
NTRA
Natera
Current Price
$187.90
Stock Insights
Strengths
Upgraded on attractively valued
Chart
$163.79 (+14.72%)
$135.84 (+38.32%)
$157.73 (+19.13%)
$123.44 (+52.22%)
NTRA Analysts Opinion
NTRA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
NTRA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NTRA Street view is extremely bullish and have positive views on the near-term outlook
NTRA has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
NTRA Earnings
The TTM data reflects the most recent 12-month period, providing overview of NTRA financial performance.
NTRA Financial Health
The company financial health has moderately improved over the past year
Financial Score
NTRA Latest Analysis
Natera : Phase 3 Trial Results Show Signatera-Guided Therapy Improves Survival In Bladder Cancer . (RTTNews) - Natera Inc. (NTRA) announced results from the randomized double-blind phase 3 IMvigor011 clinical trial in muscle-invasive bladder cancer (MIBC). The findings demonstrate that Signatera Nateras personalized molecular residual disease (MRD) test can expand the adj
Mon Oct 20, 2025
Canaccord Genuity Maintains Natera (NTRA) Buy Recommendation. Fintel reports that on October 14 2025 Canaccord Genuity maintained coverage of Natera (NasdaqGS:NTRA) with a Buy recommendation. Analyst Price Forecast Suggests 13.66% Upside
Tue Oct 14, 2025
Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular Cancer. Natera Inc. (NASDAQ:NTRA) is one of the best growth stocks to buy now. On September 30 Natera announced the publication of a validation study for its personalized molecular residual disease test Signatera in the Journal of Clinical Oncology – Precision Oncology/JCO PO. The peer-reviewed manuscript features results from the largest-ever ctDNA study in testicular cancer [….]
Mon Oct 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NTRA Stock trends
NTRA Stock performance
NTRA Stock analysis
NTRA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.